Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04223531 · ClinicalTrials.gov registry record · NA

The Natriuretic Peptide Response to Saline Infusion

A NA study of Obesity, sponsored by Vanderbilt University Medical Center.

Completed
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT04223531 is a NA study of Obesity that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 18 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04223531, a NA study of Obesity, has completed, sponsored by Vanderbilt University Medical Center.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

The primary objective is to evaluate the overarching hypothesis that obese and black individuals have relatively lower circulating natriuretic peptide levels compared with lean and white individuals. Conventional clinical assays for measurement of circulating natriuretic peptides display substantial overlap, precluding determination of the basis of the relative natriuretic peptide deficiency previously observed in these groups. We will study lean or obese, black or white, healthy adult subjects with intravenous (IV) saline infusion as a stimulus for natriuretic peptide production and release. We will measure circulating levels of natriuretic peptide isoforms using mass spectrometry that allows the specific identification of proBNP 1-108 and its cleavage product BNP 1-32.

Conditions Studied

Interventions

  • DRUG Normal Saline 0.9% Infusion Solution Bag

Study Locations (1)

Tennessee

  • Vanderbilt Univeristy - Nashville

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2020-10-26
Est. Completion 2022-06-17
Phase NA

What the Registry Record Tells You About NCT04223531

The ClinicalTrials.gov registry entry for NCT04223531 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Normal Saline 0.9% Infusion Solution Bag is the first listed.

NCT04223531 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT04223531 about?

NCT04223531 is a clinical study titled "The Natriuretic Peptide Response to Saline Infusion". The primary objective is to evaluate the overarching hypothesis that obese and black individuals have relatively lower circulating natriuretic peptide levels compared with lean and white individuals. Conventional clinical assays for measurement of circulating natriuretic peptides display substantial...

What is the current status of trial NCT04223531?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2020-10-26. Estimated completion is 2022-06-17.

What conditions does trial NCT04223531 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT04223531?

The interventions under investigation include: Normal Saline 0.9% Infusion Solution Bag (DRUG).

Who is sponsoring clinical trial NCT04223531?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04223531 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.